
AMA: Health insurance markets remain ‘stubbornly concentrated, limiting competition’
Key Takeaways
- Metropolitan commercial insurance concentration remained essentially unchanged since 2014, with 95% highly concentrated; excluding ACA exchanges, average HHI increased 401 points, indicating worsening competition outside exchanges.
- Local dominance is common: 47% of metros have one commercial insurer ≥50% share, and 11% have ≥70%, limiting contracting alternatives and leverage for physician groups.
New AMA data show limited insurer competition in commercial and Medicare Advantage markets, which can cut into physicians’ negotiating power and payment.
For physicians in many parts of the country, negotiating with a health insurer can mean bargaining with the only payer in town that matters.
Nearly all U.S. commercial health insurance markets are highly concentrated, and in 47% of metropolitan areas, a single insurer holds at least half the market, according to
“Health insurance markets across the country remain stubbornly concentrated, limiting competition and putting consumers at risk of higher costs and fewer choices,” AMA President Willie Underwood III, M.D., M.Sc., M.P.H., said in a news release.
“New research confirms that insurer consolidation can drive up premiums, underscoring the real economic consequences of market power,” he said. “Strengthening competition is essential to protecting consumers and making health care more affordable.”
Methodology
The study drew on 2025 enrollment data from Decision Resources Group covering 385 metropolitan areas, all 50 states and the District of Columbia. AMA economists José R. Guardado, Ph.D., and Carol K. Kane, Ph.D., measured concentration with the Herfindahl-Hirschman Index (HHI), the yardstick the U.S. Department of Justice (DOJ) and Federal Trade Commission (FTC) use in reviewing mergers. Under the agencies’ 2023 merger guidelines, a market with an HHI above 1,800 is highly concentrated.
Commercial markets: little change in a decade
The study found that among metropolitan commercial insurance markets in 2025:
- 95% were highly concentrated
- 90% had at least one insurer with a market share of 30% or more
- 47% had one insurer with a share of at least 50%
- 11% had one insurer with a share of at least 70%
The share of highly concentrated commercial markets has stayed between 95% and 97% since 2014. The average HHI rose 87 points over that period, but the authors said declining concentration in the Affordable Care Act exchanges masked larger increases elsewhere. Excluding the exchanges, the average HHI rose 401 points.
Nationally, UnitedHealth Group led commercial insurers with a 15% share, followed by CVS Health’s Aetna and Elevance Health at 12% each. Counted together, Blue Cross Blue Shield (BCBS) insurers held 42% of the national commercial market and had the largest share in 43 states and 84% of metro areas.
Medicare Advantage: a first uptick
Medicare Advantage (MA) markets were also highly concentrated. In 2025, 97% of metro MA markets met that threshold, down only slightly from 99% in 2017. At least one insurer held 30% or more of the market in 88% of metro areas, and one insurer held at least half in 25%.
Average MA concentration had fallen every year since 2017, but it rose for the first time in 2025, by 28 points. UnitedHealth Group held 30% of the national MA market, up from 25% in 2017, followed by Humana at 17% and CVS (Aetna) at 12%. According to the AMA, UnitedHealth Group had the largest MA share in 44% of metro areas.
Why concentration matters to physicians
Insurers sit between patients and the physicians and facilities that care for them. When an insurer dominates the market where it buys physician services, it can hold payments, and the amount of care delivered, below competitive levels. Economists call that monopsony power, the mirror image of a monopoly.
The authors explained the mechanics with a simple example. Before two insurers merge, a practice that cannot reach agreement with one can turn to the other, and that option gives the practice leverage to seek better payment. After a merger, that leverage shifts to the combined insurer and puts downward pressure on physician payment.
Practice size adds to the imbalance. The report noted that 47% of physicians who provide patient care work in practices of 10 or fewer physicians, leaving many with less bargaining power than the insurers across the table.
“When a handful of insurers dominate a market, patients face fewer choices, physicians have less negotiating power, and premiums and the quantity and quality of care can suffer,” AMA CEO and Executive Vice President John Whyte, M.D., M.P.H., wrote in the report’s foreword.
From mergers to vertical integration
The AMA has published the study for 25 years. Its earlier data helped regulators identify markets where the proposed Anthem-Cigna and Aetna-Humana deals could harm competition; the DOJ and several state attorneys general sued to block both, and both deals were abandoned.
Since then, the authors said, insurers have turned to vertical deals that draw less antitrust scrutiny, such as the Aetna-CVS merger. The largest insurers are also the largest pharmacy benefit managers, and some also operate in other health care markets. UnitedHealth Group employs almost 10,000 physicians, according to the report, which said the dominance of such large systems denies independent physicians the ability to compete fairly.
AHIP has disputed past editions of the study, arguing in a
The AMA said the findings reinforce the need for continued antitrust scrutiny of insurer consolidation, a recurring
State and metro-level tables are available through the AMA’s
Related to this article









